Entèmedyè nan remazolam benzenesulfonate (CAS No 308242-23-1)
Sinonim:(3S)-(7-bromo-2-oxo-5-piridin-2-il-2, 3-dihydro-1H-benzo [E] [1,4] diazepin-3-il) -propionic asid methylester; Methyl3-[(3s) -7-bromo-2-oxo-5- (2-piridinil) -2, 3-dihydro-1H-1, 4-benzodiazepin-3-il] propanoate; (S) -methyl3- (7-bromo-2-oxo-5- (piridin-2-il) -2, 3-dihydro-1H-benzo [E] [1,4] diazepin-3-il) propanoate; 3-[(s) -7-bromo-2-oxo-5-piridin-2-il-2, 3-dihydro-1H-1, 4-benzodiazepin-3-il] -propionicacidmethylester.
CAS NO.:308242-23-1
Fòmil molekilè:C18H16Brn3O3
Pwa molekilè:402.24
Aplikasyon: Edikaman, entèmedyè, APIs, sentèz koutim, pwodwi chimik yo
Itilizasyon:Entèmedyè nan remazolam benzenesulfonate

Estrikti
Siperyorite:Pi bon vandè, kalite siperyè, pri konpetitif, livrezon vit, repons rapid
Kategori ki gen rapò:Pwodwi chimik amann

Pwen bouyi | 545.3 ± 50.0 ° C (prevwa) |
Densite | 1.52 ± 0.1 g/cm3 (prevwa) |
Kondisyon depo | Sele nan tanperati sèk, chanm |
pka | 11.15 ± 0.70 (prevwa) |
Espesifikasyon espesyal dapre kondisyon kliyan yo | |
Aparisyon | Blan pou poud jòn |
Dlo | 1.0% max |
Isomè | 1.5%max |
Pite | 98.0 % Min |
Prekosyon pou manyen san danje:
Manyen nan yon kote ki byen ayere. Mete rad pwoteksyon apwopriye. Evite kontak ak po ak je. Evite fòmasyon pousyè ak aerosol. Sèvi ak zouti ki pa gen okenn parapò. Anpeche dife ki te koze pa vapè Electrostatic egzeyat.
Kondisyon pou depo ki an sekirite, ki gen ladan nenpòt ki enkonpatibilite:
Sere veso a byen fèmen nan yon kote ki sèk, fre ak byen ayere. Sere apa de resipyan alimenter oswa materyèl enkonpatib.
Jingye gen 86 kouche nan réacteurs nan total, nan ki volumn nan reaktè emaye se 69, ki soti nan 50 a 3000L. Nimewo a nan réacteurs pur se 18, ki soti nan 50 a 3000L. QC ekipe ak dè santèn de tout kalite enstriman analyse. Li ka satisfè pwodiksyon komèsyal la ak analiz konplè nan pwodwi an. Pwodwi sa a se yon pwodwi plas siperyè epi yo ka delivre selon bezwen kliyan yo.
Jiangsu Jingye Pharmaceutical Co., Ltd. is formerly named Jintan Depei Chemical Co., Ltd. which established in 1994, and turns to a professional pharmaceutical manufacturer in 2016. After two decades of development, Jingye Pharmaceutical has grown to a professional and comprehensive pharmaceutical enterprise combining R&D, production, import and export with two subsidiaries located in Shanghai and Lianyungang.